Table IV.

Details of cutaneous malignancies in the liver transplant cohort

Cancer/precancer type	Time after transplant; No. of patients (%)	Location; No. of patients (%)	Immunosuppressive agents >6 months; No. of patients
Basal cell carcinoma	<5 years; 0 5-10 years; 1 (100) >10 years; 0	Sun exposed; 0 Non–sun exposed; 1 (100)	Tacrolimus; 1 Mycophenolate mofetil; 0 Prednisolone; 0
Bowen disease	<5 years; 1 (33) 5-10 years; 2 (67) >10 years; 0	Sun exposed; 2 (67) Non–sun exposed; 1 (33)	Tacrolimus; 3 Mycophenolate mofetil; 3 Prednisolone; 2
Actinic keratosis	<5 years; 1 (17) 5-10 years; 2 (33) >10 years; 3 (50)	Sun exposed; 6 (100) Non–sun exposed; 0	Tacrolimus; 6 Mycophenolate mofetil; 5 Prednisolone; 3 Cyclosporine; 1